| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692074 | European Urology | 2017 | 12 Pages |
Abstract
Our observation showed that some of subtype-enriched mutations and copy number aberrations are clinically actionable, which has direct implications for the clinical management of patients with bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Woonyoung Choi, Andrea Ochoa, David J. McConkey, Mattias Aine, Mattias Höglund, William Y. Kim, Francisco X. Real, Anne E. Kiltie, Ian Milsom, Lars Dyrskjøt, Seth P. Lerner,